Because LICN has essentially no credible, current sell-side analyst price targets — major data providers list "N/A" for both analysts and price target — the $1.00 objective used here is a fallback derived from public discussion and technical milestones rather than an analyst consensus. The $1.00 level is a natural psychological round number that also sits just above a former trading zone the stock occupied in September and October 2026, when shares changed hands in the roughly $0.87 to $1.17 area before the most recent leg lower. Any single price objective for a distressed micro-cap should be treated with caution, and no claim is made that the stock will reach this level.
LICN traded near $0.51 in early November 2026, close to the low end of its 52-week range after a prolonged collapse from a high around $9.49. Reaching $1.00 would therefore require an upside of roughly 96%, which qualifies as a very large move given the stock's size and trend. The company, formerly Lichen China Limited, completed a reverse stock split and name change effective in early 2025. Its fundamentals have deteriorated: fiscal 2025 revenue declined about 41% to roughly $24.5 million, and the company reported a net loss for the year. For the six months ended June 30, 2026, revenue fell to about $10.3 million from $14.3 million a year earlier, with a net loss of about $11.6 million. With a market capitalization near $9 million, the path toward $1.00 would likely require both a stabilization in the share price and a meaningful improvement in the operating business.
The main factor that could support a rebound is the sheer depth of the decline itself. Stocks that have fallen sharply can experience sharp, short-covering rallies, particularly when short interest has been rising, as it reportedly did in mid-2026. The $1.00 psychological level could act as a magnet if a recovery gathers momentum, and the company's efforts to streamline operations — including the sale of a loss-making subsidiary to improve financial health — signal management is attempting to restore profitability. A return to revenue growth or a narrower loss in a future report, along with any resolution of its Nasdaq listing-compliance issues, would be the clearest fundamental catalysts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The risks are substantial. LICN has received a Nasdaq delisting notice related to listing-rule non-compliance, and a $500 million mixed securities shelf filing raises the possibility of further dilution. Revenue is contracting, losses are mounting, and the company's market capitalization has collapsed. Extreme volatility — including multiple trading halts — makes sustained recoveries difficult to establish, and a stock trading below $1.00 faces additional structural and liquidity pressures. Without a credible fundamental turnaround, the trend strongly favors continued downside rather than a doubling back to $1.00.
From a technical standpoint, the 52-week high near $9.49 now acts as a distant reference point rather than a relevant resistance zone. The more meaningful structure is the long, sustained downtrend that has taken the stock from several dollars to under $1.00. The $1.00 mark is the key psychological resistance, while the prior consolidation zone between roughly $0.87 and $1.17 represents the first meaningful overhead supply if a recovery develops. On the downside, the recent lows near $0.51 (and any prints below that) are the levels to watch for signs of stabilization.
Analyst price targets typically reflect a roughly 12-month research horizon, but no such targets exist for LICN, so the $1.00 objective carries no defined time frame. Investors should monitor the company's next earnings release and its revenue trajectory, any updates on Nasdaq listing compliance, and further news on asset sales or capital-raising that could affect the share count. Trading halts, short-interest data, and volume patterns will also matter, given how thinly and erratically the stock trades.
The question of whether LICN can reach $1.00 rests on a fallback price objective drawn from the psychological round-number level and former trading range, not on an analyst consensus, since no credible analyst coverage exists. The required move of roughly 96% is very large, and it stands against weakening revenue, mounting losses, a delisting notice, and a deeply broken downtrend. The strongest potential support is a stabilization and fundamental turnaround, while the principal obstacles are structural and financial. Investors should watch earnings, listing-compliance news, and whether the stock can hold above recent lows before treating $1.00 as anything more than a distant recovery benchmark.
I have found Tickeron's AI Daily Buy/Sell Signals useful for monitoring stocks like this one. The tool applies artificial intelligence to track thousands of securities in real time and produces Buy, Sell, or Hold signals based on technical behavior and market shifts. For a volatile, low-liquidity name such as LICN, it helps identify momentum changes more efficiently than manual review alone, allowing traders to stay on top of potential turning points.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where LICN advanced for three days, in 161 of 184 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
LICN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LICN as a result. In 65 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for LICN turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In 27 of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LICN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for LICN entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.116) is normal, around the industry mean (5.887). P/E Ratio (0.008) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.221) is also within normal values, averaging (9.907).
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. LICN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LICN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OfficeEquipmentSupplies